Whitehawk Therapeutics, formerly Aadi Bioscience, has repositioned itself as a next-generation antibody-drug conjugate (ADC) company focused on cancer treatment. The company in-licensed three ADC programs from WuXi Biologics targeting tumor markers PTK7, MUC16, and SEZ6. Two programs, HWK-007 and HWK-016, entered Phase I clinical trials earlier this year, while the third, HWK-206, is set to start trials this quarter. This strategic shift highlights Whitehawk's commitment to developing innovative cancer therapies with potential clinical impact.
Whitehawk Therapeutics, Inc. is the subject of this update, with Pluang market data providing context for readers. As of Sep 16, 2026 02:01 WIB, among 91 priced Health-sector US stocks tradable on Pluang, 24 rose and 66 fell. Notable movers include Ascendis Pharma A/S (ASND) at USD 235.61 with a -11.06% change, Adaptive Biotechnologies Corp (ADPT) at USD 27.22 with a +9.85% change, and Illumina, Inc. (ILMN) at USD 222.67 with a +6.94% change.
Sika AG posted a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite currency headwinds. The company saw organic growth of 3.5% and improved material margins to 55.4%, with EBITDA rising 1.9% t...
Sika reported a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite a negative currency effect. The company improved its material margin to 55.4% and maintained an EBITDA margin of 19.2%, with ...
Aduro Clean Technologies announced its participation in five major industry and investor conferences from October to December 2026. The company will showcase progress in its Hydrochemolytic™ technology for recycling plastics and upgrading crude oils,...
Aduro Clean Technologies announced it will participate in five conferences between October and December 2026, engaging with industry professionals and institutional investors. Key topics include updates on their Hydrochemolytic™ technology for recycl...
Remittix has raised $33 million in its presale, nearing its $36 million hard cap ahead of its November 24, 2026 launch. The project offers a PayFi ecosystem connecting crypto with bank payments, with active product use and testing underway. Meanwhile...
